求人・転職情報
6件中の1〜6件を表示
仕事内容
（雇入れ直後）
Oncology Research-Focused Scientific Engagement & Strategic Communications (Japan Support)
・Support the development of scientific narratives for early-stage oncology assets in partnership with Japan and global Oncology Research leads, ensuring alignment with the broader global scientific strategy and corporate narrative.
・Execute strategic scientific messaging for oncology assets from drug discovery through Proof of Concept (POC), with a focus on relevance for the Japan research environment and scientific community.
・Provide tactical support to global and regional AMTs on early data dissemination plans, ensuring alignment with asset development and communication strategies for the Japan region.
・Partner with Japan Corporate Communications to integrate early-stage scientific messaging into regional external engagement strategies, ensuring alignment with global guidance.
・Collaborate with global and regional Scientific Publications teams to align on scientific communication platforms, ensuring a unified strategy for the early oncology pipeline.
・Support the integration of early-phase scientific communication with data-driven insights by liaising with QSEQ’s biostatistics, RWE, and epidemiology teams to contribute to evidence-backed communication materials.
Oncology Early Pipeline Publications & Content Strategy (Regional Execution)
・Support the implementation of global publication plans to ensure early-phase oncology assets are strategically positioned in regional and global scientific discourse.
・Assist in developing and executing publication strategies in collaboration with Subject Matter Experts (SMEs) within Japan R&D for early-phase pipeline publications.
・Leverage established global scientific platforms to enhance publications and optimize content for potential re-use in regional contexts.
・Ensure regional publication activities align with evolving scientific data and global early clinical development priorities.
Content Development & Scientific Communications Support
・Develop and adapt centralized scientific content for early-phase oncology assets to support regional Medical Information and Medical Education functions in Japan.
・Support Japan Medical Information content review for early pipeline scientific accuracy and consistency.
・Assist in guiding digital publication enhancements and publication extenders for early-phase oncology assets in the region.
Cross-Functional Collaboration & Stakeholder Engagement
・Ensure close collaboration with Japan and global Scientific Publications teams while maintaining a distinct focus on early-stage asset communications.
・Engage with Japan clinical, regulatory, and research teams to ensure that early-phase scientific insights are strategically communicated and aligned across functions.
・Represent the Japan early scientific engagement activities in internal discussions, contributing to strategic alignment between regional and global pipeline development efforts.
This position reports to an Executive Director.
This position is an individual contributor role.
This position is a hybrid position.
This position is part of the Quantitative Sciences and Evidence Generations group. Cell and Gene Therapy & Biopharma, or Exploratory statistics in SRS.
（変更の範囲）
会社内での全ての業務
Oncology Research-Focused Scientific Engagement & Strategic Communications (Japan Support)
・Support the development of scientific narratives for early-stage oncology assets in partnership with Japan and global Oncology Research leads, ensuring alignment with the broader global scientific strategy and corporate narrative.
・Execute strategic scientific messaging for oncology assets from drug discovery through Proof of Concept (POC), with a focus on relevance for the Japan research environment and scientific community.
・Provide tactical support to global and regional AMTs on early data dissemination plans, ensuring alignment with asset development and communication strategies for the Japan region.
・Partner with Japan Corporate Communications to integrate early-stage scientific messaging into regional external engagement strategies, ensuring alignment with global guidance.
・Collaborate with global and regional Scientific Publications teams to align on scientific communication platforms, ensuring a unified strategy for the early oncology pipeline.
・Support the integration of early-phase scientific communication with data-driven insights by liaising with QSEQ’s biostatistics, RWE, and epidemiology teams to contribute to evidence-backed communication materials.
Oncology Early Pipeline Publications & Content Strategy (Regional Execution)
・Support the implementation of global publication plans to ensure early-phase oncology assets are strategically positioned in regional and global scientific discourse.
・Assist in developing and executing publication strategies in collaboration with Subject Matter Experts (SMEs) within Japan R&D for early-phase pipeline publications.
・Leverage established global scientific platforms to enhance publications and optimize content for potential re-use in regional contexts.
・Ensure regional publication activities align with evolving scientific data and global early clinical development priorities.
Content Development & Scientific Communications Support
・Develop and adapt centralized scientific content for early-phase oncology assets to support regional Medical Information and Medical Education functions in Japan.
・Support Japan Medical Information content review for early pipeline scientific accuracy and consistency.
・Assist in guiding digital publication enhancements and publication extenders for early-phase oncology assets in the region.
Cross-Functional Collaboration & Stakeholder Engagement
・Ensure close collaboration with Japan and global Scientific Publications teams while maintaining a distinct focus on early-stage asset communications.
・Engage with Japan clinical, regulatory, and research teams to ensure that early-phase scientific insights are strategically communicated and aligned across functions.
・Represent the Japan early scientific engagement activities in internal discussions, contributing to strategic alignment between regional and global pipeline development efforts.
This position reports to an Executive Director.
This position is an individual contributor role.
This position is a hybrid position.
This position is part of the Quantitative Sciences and Evidence Generations group. Cell and Gene Therapy & Biopharma, or Exploratory statistics in SRS.
（変更の範囲）
会社内での全ての業務
求める経験 / スキル
【応募要件 / Qualifications】
＜必須 / Required＞
・Advanced degree (MS, PhD, PharmD, or MD) in Life Sciences, Oncology, or a related field.
・5+ years of experience in scientific communications, medical affairs, publications, or a related role within the pharmaceutical or biotech industry, with a focus on oncology.
・Experience in early-phase drug development and scientific engagement, preferably within a Japan or global context.
・Understanding of publication planning and execution, particularly for early-stage assets.
・Proven ability to collaborate effectively with cross-functional teams, including research, clinical development, and communications.
・Excellent scientific writing, presentation, and stakeholder engagement skills in both Japanese and English.
・Strong organizational and project management skills, with the ability to manage multiple priorities.
・Ability to translate complex scientific data into clear and impactful communication materials.
＜歓迎 / Preferred＞
・8+ years of relevant experience in oncology-focused scientific communications.
・Experience working in a global matrix organization and navigating regional/global dynamics.
・Experience supporting or working with research teams in a discovery or translational science setting.
・Familiarity with the Japan pharmaceutical industry landscape and key scientific audiences.
・Flexibility to travel domestically and internationally as needed.
This Japan-based role is critical for ensuring regional scientific insights are integrated into the global narrative for Astellas’ early oncology pipeline, enabling effective, evidence-backed communication that supports value creation in the Japan market and beyond.
＜必須 / Required＞
・Advanced degree (MS, PhD, PharmD, or MD) in Life Sciences, Oncology, or a related field.
・5+ years of experience in scientific communications, medical affairs, publications, or a related role within the pharmaceutical or biotech industry, with a focus on oncology.
・Experience in early-phase drug development and scientific engagement, preferably within a Japan or global context.
・Understanding of publication planning and execution, particularly for early-stage assets.
・Proven ability to collaborate effectively with cross-functional teams, including research, clinical development, and communications.
・Excellent scientific writing, presentation, and stakeholder engagement skills in both Japanese and English.
・Strong organizational and project management skills, with the ability to manage multiple priorities.
・Ability to translate complex scientific data into clear and impactful communication materials.
＜歓迎 / Preferred＞
・8+ years of relevant experience in oncology-focused scientific communications.
・Experience working in a global matrix organization and navigating regional/global dynamics.
・Experience supporting or working with research teams in a discovery or translational science setting.
・Familiarity with the Japan pharmaceutical industry landscape and key scientific audiences.
・Flexibility to travel domestically and internationally as needed.
This Japan-based role is critical for ensuring regional scientific insights are integrated into the global narrative for Astellas’ early oncology pipeline, enabling effective, evidence-backed communication that supports value creation in the Japan market and beyond.
従業員数
14,754名
（（2024年3月31日現在、連結ベース））
勤務地
東京都
想定年収
1,300 万円 ~ 1,700 万円
従業員数
14,754名
（（2024年3月31日現在、連結ベース））
仕事内容
仕事内容：
創薬研究プロジェクト加速のため、現場研究者との議論を通じて研究データ・ナレッジ利活用における本質的・潜在的な課題やニーズを同定し、最新のデジタルIT技術を活用して解決に導く。
それらを実現するための中長期戦略を立案し、研究員および部門マネジメントとの議論を通じた組織的意識改革および戦略遂行を実践することで意思決定サイクルを加速する。
将来的なマネジャーもしくはプロフェッショナル職候補として、多様なメンバーを巻き込みプロジェクト推進をリードするとともに、周囲のロールモデルとなり継続的な組織のケイパビリティ向上に貢献する。
創薬研究プロジェクト加速のため、現場研究者との議論を通じて研究データ・ナレッジ利活用における本質的・潜在的な課題やニーズを同定し、最新のデジタルIT技術を活用して解決に導く。
それらを実現するための中長期戦略を立案し、研究員および部門マネジメントとの議論を通じた組織的意識改革および戦略遂行を実践することで意思決定サイクルを加速する。
将来的なマネジャーもしくはプロフェッショナル職候補として、多様なメンバーを巻き込みプロジェクト推進をリードするとともに、周囲のロールモデルとなり継続的な組織のケイパビリティ向上に貢献する。
求める経験 / スキル
求める経験
・データサイエンス分野で独自の専門性を確立し、チームや部門の技術戦略を主導した実務経験
・多様な技術チームや専門家グループを横断的に統括し、プロジェクト・組織をリードした実務経験
求めるスキル・知識・能力
・創薬研究者と議論するためのライフサイエンス領域における修士相当レベルの知見（必須）
・大規模/複雑なデータ処理・分析スキル（データ基盤設計、パイプライン開発/システム連携、AI/ML応用を含むエンジニアリングなど）（必須）
・データサイエンス分野で独自の専門性を確立し、チームや部門の技術戦略を主導した実務経験
・多様な技術チームや専門家グループを横断的に統括し、プロジェクト・組織をリードした実務経験
求めるスキル・知識・能力
・創薬研究者と議論するためのライフサイエンス領域における修士相当レベルの知見（必須）
・大規模/複雑なデータ処理・分析スキル（データ基盤設計、パイプライン開発/システム連携、AI/ML応用を含むエンジニアリングなど）（必須）
勤務地
神奈川県
想定年収
1,000 万円 ~ 1,600 万円
大手製薬企業
仕事内容
主な業務内容：
・組織または特定の治療領域の戦略的な科学的、治療的、および商業的ニーズを満たす事業開発機会を創出する。
・リーダーシップと戦略構築
・プロジェクト管理：メディカルケミストリープロジェクトの設計、実行、および管理を監督し、タイムリーな進捗と高品質な成果を確保する。
・チーム開発：社内の毛ミスとチームを指導・育成し、協力的で革新的な職場環境を醸成する。
・他部門との横断的なコラボレーションの推進
・組織または特定の治療領域の戦略的な科学的、治療的、および商業的ニーズを満たす事業開発機会を創出する。
・リーダーシップと戦略構築
・プロジェクト管理：メディカルケミストリープロジェクトの設計、実行、および管理を監督し、タイムリーな進捗と高品質な成果を確保する。
・チーム開発：社内の毛ミスとチームを指導・育成し、協力的で革新的な職場環境を醸成する。
・他部門との横断的なコラボレーションの推進
求める経験 / スキル
・Expected education and experience: PhD degree in Chemistry, Medicinal Chemistry or related discipline with 15+ years experience in small molecule projects.
・Proven track record of leading successful drug discovery programs, preferably in large pharma.
・Leadership Skills: Strong leadership and managerial skills with experience leading and developing high-performing teams.
・Technical Expertise: Deep understanding of medicinal chemistry principles, drug design, and optimization processes.
・Communication: Excellent verbal and written communication skills, with the ability to effectively communicate complex scientific concepts to a broad audience.
・Problem-Solving: Strong analytical and problem-solving skills, with a proactive and innovative approach to challenges.
・Collaboration: Proven ability to work collaboratively in a cross-functional team environment.
・Adaptability: Ability to adapt to changing priorities and work effectively in a fast-paced and dynamic environment.
・Proven track record of leading successful drug discovery programs, preferably in large pharma.
・Leadership Skills: Strong leadership and managerial skills with experience leading and developing high-performing teams.
・Technical Expertise: Deep understanding of medicinal chemistry principles, drug design, and optimization processes.
・Communication: Excellent verbal and written communication skills, with the ability to effectively communicate complex scientific concepts to a broad audience.
・Problem-Solving: Strong analytical and problem-solving skills, with a proactive and innovative approach to challenges.
・Collaboration: Proven ability to work collaboratively in a cross-functional team environment.
・Adaptability: Ability to adapt to changing priorities and work effectively in a fast-paced and dynamic environment.
勤務地
神奈川県
想定年収
1,700 万円 ~ 2,400 万円
武田薬品工業株式会社
仕事内容
（Purpose）
Leveraging a proven track record of leading at least 3 discovery programs to clinic, The Global Therapeutic Research Lead (G-TRL) is a pipeline critical strategic leader responsible for driving Research projects to the clinic. The individual will sit on the Neuroscience Drug Discovery Unit (NS DDU) Leadership Team.
Leader for at least one or more of Takeda’s top priority oligonucleotide projects with substantial clinical and commercial potential with a clear accelerated path to the clinic.
You will provide mentorship to team members to elevate enterprise thinking and capabilities of our drug discovery talent across the global Research function.
As project lead, the G-TRL builds a connected view of the project within the Neuroscience TA strategy and treatment paradigm and can represent all core expertise at depth and align with stakeholders and sponsors across the organization including Research, Clinical Development and Commercial stakeholders and executive level governance committees.
G-TRLs are responsible for creating the medicine vision, early asset strategy and managing multiple external partnerships that accelerate delivery of the project.
G-TRLs will establish smart, fast, and critical path minded practices for groups, including integrating new strategies and competitive industry ways of working.
G-TRL will advise on the continuous infusion of new Research projects aligned to strategy to generate a sustainable Research Engine generating a steady flow of high-quality INDs every year.
（Accountabilities）
Lead and manage one or more ‘Top 10’ drug discovery oligonucleotide projects, overseeing the entire drug discovery process from target identification to preclinical development. (Top 10 projects are well validated targets that are focused on strategically aligned modalities with substantial clinical and commercial potential)
Responsible for the articulation and ownership of the project strategy, developed in partnership with internal stakeholders.
Contribute to strategy for future portfolio investment, particularly within the Inflammation and Immunology area including advising on which projects should be Top 10 projects.
Evaluate and prioritize potential drug candidates based on scientific, medical, and commercial considerations.
Represent all core expertise for project.
Partner with Clinical and Translational teams to refine asset strategy.
Ensure alignment to the therapeutic area strategy (i.e., Clinical Development).
Understand and align with commercial team for asset commercial value within the Neuroscience Therapeutic Area (NS TA).
Provide guidance and mentorship to global project team members, stimulating enterprise thinking and fostering their professional growth and development.
Mentor future and more junior project leads and elevate drug discovery capability across Research.
Collaborate with cross-functional teams and partners (e.g., DMPK, Pharmaceutical Sciences) within and outside Takeda to drive project delivery.
Pipeline and enterprise impact through effective partnering with multiple internal and external collaborators.
Provide strategic, process, and operational leadership for successful Top 10 Project delivery.
Foster a culture of innovation and scientific excellence within the matrixed drug discovery team, promoting collaboration, knowledge sharing, and continuous learning.
Become a world leading scientific expert in the projects you lead.
Oversee the design and execution of experiments, data analysis, and interpretation to enable decision-making and optimize drug discovery efforts.
Stay abreast of the latest advancements in drug discovery, emerging technologies, and industry trends, applying this knowledge to enhance drug discovery strategies.
Build and maintain relationships with key stakeholders, including academic institutions, research organizations, and industry partners inclusive of serving on joint external governance committees across the globe.
Represent Takeda externally for the Neuroscience Drug Discovery Unit and play a key role in evaluating external opportunities, serving as an effective ambassador for Takeda’s global business development brand.
Leveraging a proven track record of leading at least 3 discovery programs to clinic, The Global Therapeutic Research Lead (G-TRL) is a pipeline critical strategic leader responsible for driving Research projects to the clinic. The individual will sit on the Neuroscience Drug Discovery Unit (NS DDU) Leadership Team.
Leader for at least one or more of Takeda’s top priority oligonucleotide projects with substantial clinical and commercial potential with a clear accelerated path to the clinic.
You will provide mentorship to team members to elevate enterprise thinking and capabilities of our drug discovery talent across the global Research function.
As project lead, the G-TRL builds a connected view of the project within the Neuroscience TA strategy and treatment paradigm and can represent all core expertise at depth and align with stakeholders and sponsors across the organization including Research, Clinical Development and Commercial stakeholders and executive level governance committees.
G-TRLs are responsible for creating the medicine vision, early asset strategy and managing multiple external partnerships that accelerate delivery of the project.
G-TRLs will establish smart, fast, and critical path minded practices for groups, including integrating new strategies and competitive industry ways of working.
G-TRL will advise on the continuous infusion of new Research projects aligned to strategy to generate a sustainable Research Engine generating a steady flow of high-quality INDs every year.
（Accountabilities）
Lead and manage one or more ‘Top 10’ drug discovery oligonucleotide projects, overseeing the entire drug discovery process from target identification to preclinical development. (Top 10 projects are well validated targets that are focused on strategically aligned modalities with substantial clinical and commercial potential)
Responsible for the articulation and ownership of the project strategy, developed in partnership with internal stakeholders.
Contribute to strategy for future portfolio investment, particularly within the Inflammation and Immunology area including advising on which projects should be Top 10 projects.
Evaluate and prioritize potential drug candidates based on scientific, medical, and commercial considerations.
Represent all core expertise for project.
Partner with Clinical and Translational teams to refine asset strategy.
Ensure alignment to the therapeutic area strategy (i.e., Clinical Development).
Understand and align with commercial team for asset commercial value within the Neuroscience Therapeutic Area (NS TA).
Provide guidance and mentorship to global project team members, stimulating enterprise thinking and fostering their professional growth and development.
Mentor future and more junior project leads and elevate drug discovery capability across Research.
Collaborate with cross-functional teams and partners (e.g., DMPK, Pharmaceutical Sciences) within and outside Takeda to drive project delivery.
Pipeline and enterprise impact through effective partnering with multiple internal and external collaborators.
Provide strategic, process, and operational leadership for successful Top 10 Project delivery.
Foster a culture of innovation and scientific excellence within the matrixed drug discovery team, promoting collaboration, knowledge sharing, and continuous learning.
Become a world leading scientific expert in the projects you lead.
Oversee the design and execution of experiments, data analysis, and interpretation to enable decision-making and optimize drug discovery efforts.
Stay abreast of the latest advancements in drug discovery, emerging technologies, and industry trends, applying this knowledge to enhance drug discovery strategies.
Build and maintain relationships with key stakeholders, including academic institutions, research organizations, and industry partners inclusive of serving on joint external governance committees across the globe.
Represent Takeda externally for the Neuroscience Drug Discovery Unit and play a key role in evaluating external opportunities, serving as an effective ambassador for Takeda’s global business development brand.
求める経験 / スキル
Education & Competencies (Technical and Behavioral):
Advanced degree in health or life sciences (e.g., Ph.D., M.D., D.V.M.)
Expected to have at least 10-12 years industry and relevant subject matter expertise within Immunology and Inflammation and at least 10-12 years global management experience, including working effectively with matrix teams.
Extensive experience in leading drug discovery teams and managing drug discovery/development projects, preferably in a pharmaceutical or biotechnology setting covering gastroenterology and inflammation.
Deep understanding of the drug discovery process, including target identification, hit-to-lead optimization, and preclinical development, anticipating, and removing roadblocks.
Proven track record of leading numerous projects, ideally 5+ projects, across discovery from target inception to Candidate Nomination or beyond.
Played a major role in 3+ INDs.
Has delivered clinical development assets preferably across multiple modalities (e.g. small molecule, biologics, cell therapies, ADC etc.)
Excellent and inclusive leadership with the ability to inspire and motivate diverse teams towards achieving ambitious goals.
Reputation as a proactive, solutions-oriented leader who engages relevant expertise no matter where it resides.
Strong business acumen and understanding of the pharmaceutical industry, including regulatory requirements and commercial considerations with relevant knowledge and expertise for specific modalities.
Exceptional communication and presentation skills, with the ability to effectively communicate complex scientific concepts to diverse audiences.
Proven ability to build and maintain collaborative relationships with internal and external stakeholders across a matrixed organization.
Strong problem-solving and decision-making abilities, with a focus on data-driven decision making.
Demonstrated success in building and managing strategic partnerships with academic institutions, research organizations, and industry collaborators.
Advanced degree in health or life sciences (e.g., Ph.D., M.D., D.V.M.)
Expected to have at least 10-12 years industry and relevant subject matter expertise within Immunology and Inflammation and at least 10-12 years global management experience, including working effectively with matrix teams.
Extensive experience in leading drug discovery teams and managing drug discovery/development projects, preferably in a pharmaceutical or biotechnology setting covering gastroenterology and inflammation.
Deep understanding of the drug discovery process, including target identification, hit-to-lead optimization, and preclinical development, anticipating, and removing roadblocks.
Proven track record of leading numerous projects, ideally 5+ projects, across discovery from target inception to Candidate Nomination or beyond.
Played a major role in 3+ INDs.
Has delivered clinical development assets preferably across multiple modalities (e.g. small molecule, biologics, cell therapies, ADC etc.)
Excellent and inclusive leadership with the ability to inspire and motivate diverse teams towards achieving ambitious goals.
Reputation as a proactive, solutions-oriented leader who engages relevant expertise no matter where it resides.
Strong business acumen and understanding of the pharmaceutical industry, including regulatory requirements and commercial considerations with relevant knowledge and expertise for specific modalities.
Exceptional communication and presentation skills, with the ability to effectively communicate complex scientific concepts to diverse audiences.
Proven ability to build and maintain collaborative relationships with internal and external stakeholders across a matrixed organization.
Strong problem-solving and decision-making abilities, with a focus on data-driven decision making.
Demonstrated success in building and managing strategic partnerships with academic institutions, research organizations, and industry collaborators.
従業員数
5,486名
（単体 (連結 49,095名) ※2023年3月末時点）
勤務地
神奈川県
想定年収
1,150 万円 ~ 1,650 万円
従業員数
5,486名
（単体 (連結 49,095名) ※2023年3月末時点）
再生医療
仕事内容
【業務内容】
がん免疫の治療と幹細胞治療の研究をお任せします。
短期的な目標としては、現在既に活用している細胞治療のさらなる改善
長期的には、今後臨床で活用可能な、これまでにない新たな治療法の確立を目指しております。
・新しい細胞治療技術の研究/開発
・臨床応用に向けたデータ解析および報告書作成
・幹細胞/免疫細胞の培養/品質管理
・細胞培養技術の最適化（増殖効率向上、安全性評価など）
・フローサイト、PCRなどを用いた細胞解析
・臨床応用に向けたデータ解析および報告書作成
がん免疫の治療と幹細胞治療の研究をお任せします。
短期的な目標としては、現在既に活用している細胞治療のさらなる改善
長期的には、今後臨床で活用可能な、これまでにない新たな治療法の確立を目指しております。
・新しい細胞治療技術の研究/開発
・臨床応用に向けたデータ解析および報告書作成
・幹細胞/免疫細胞の培養/品質管理
・細胞培養技術の最適化（増殖効率向上、安全性評価など）
・フローサイト、PCRなどを用いた細胞解析
・臨床応用に向けたデータ解析および報告書作成
求める経験 / スキル
【必須】
・博士号(生命科学・医学・薬学・工学等）または同等以上の経験
・細胞培養(幹細胞・iPS細胞・免疫細胞等)3年以上推奨
・分子細胞生物学や再生医療の分野経験
・研究倫理および再生医療関連法規制に関する基礎理解
・基本的な分子生物学的実験スキル
・マネジメント経験
【歓迎条件】
• 幹細胞やiPS細胞を用いた分化誘導・品質評価の実務経験
• GMP/GCTP施設での研究または製造プロセス経験
• 臨床研究・治験への関与経験（プロトコル作成、データ解析、規制当局対応）
• 遺伝子工学・分子生物学・細胞薬理学などの研究経験
• ラボ運営・チームリードなどの経験豊富な方
・博士号(生命科学・医学・薬学・工学等）または同等以上の経験
・細胞培養(幹細胞・iPS細胞・免疫細胞等)3年以上推奨
・分子細胞生物学や再生医療の分野経験
・研究倫理および再生医療関連法規制に関する基礎理解
・基本的な分子生物学的実験スキル
・マネジメント経験
【歓迎条件】
• 幹細胞やiPS細胞を用いた分化誘導・品質評価の実務経験
• GMP/GCTP施設での研究または製造プロセス経験
• 臨床研究・治験への関与経験（プロトコル作成、データ解析、規制当局対応）
• 遺伝子工学・分子生物学・細胞薬理学などの研究経験
• ラボ運営・チームリードなどの経験豊富な方
勤務地
東京都
想定年収
1,000 万円 ~ 2,000 万円
再生医療
仕事内容
がん免疫の治療と幹細胞治療の研究をお任せします。
短期的な目標としては、現在既に活用している細胞治療のさらなる改善
長期的には、今後臨床で活用可能な、これまでにない新たな治療法の確立を目指しております。
・新しい細胞治療技術の研究/開発
・臨床応用に向けたデータ解析および報告書作成
・幹細胞/免疫細胞の培養/品質管理
・細胞培養技術の最適化（増殖効率向上、安全性評価など）
・フローサイト、PCRなどを用いた細胞解析
・臨床応用に向けたデータ解析および報告書作成
短期的な目標としては、現在既に活用している細胞治療のさらなる改善
長期的には、今後臨床で活用可能な、これまでにない新たな治療法の確立を目指しております。
・新しい細胞治療技術の研究/開発
・臨床応用に向けたデータ解析および報告書作成
・幹細胞/免疫細胞の培養/品質管理
・細胞培養技術の最適化（増殖効率向上、安全性評価など）
・フローサイト、PCRなどを用いた細胞解析
・臨床応用に向けたデータ解析および報告書作成
求める経験 / スキル
【必須】
・博士号(生命科学・医学・薬学・工学等）または同等以上の経験
・細胞培養(幹細胞・iPS細胞・免疫細胞等)3年以上推奨
・分子細胞生物学や再生医療の分野経験
・研究倫理および再生医療関連法規制に関する基礎理解
・基本的な分子生物学的実験スキル
・マネジメント経験
【歓迎条件】
• 幹細胞やiPS細胞を用いた分化誘導・品質評価の実務経験
• GMP/GCTP施設での研究または製造プロセス経験
• 臨床研究・治験への関与経験（プロトコル作成、データ解析、規制当局対応）
• 遺伝子工学・分子生物学・細胞薬理学などの研究経験
• ラボ運営・チームリードなどの経験豊富な方
・博士号(生命科学・医学・薬学・工学等）または同等以上の経験
・細胞培養(幹細胞・iPS細胞・免疫細胞等)3年以上推奨
・分子細胞生物学や再生医療の分野経験
・研究倫理および再生医療関連法規制に関する基礎理解
・基本的な分子生物学的実験スキル
・マネジメント経験
【歓迎条件】
• 幹細胞やiPS細胞を用いた分化誘導・品質評価の実務経験
• GMP/GCTP施設での研究または製造プロセス経験
• 臨床研究・治験への関与経験（プロトコル作成、データ解析、規制当局対応）
• 遺伝子工学・分子生物学・細胞薬理学などの研究経験
• ラボ運営・チームリードなどの経験豊富な方
勤務地
東京都
想定年収
2,000 万円 ~ 3,000 万円
-
職種から求人を探す
-
業種から求人を探す
-
勤務地から求人を探す
-
年収から求人を探す
転職支援サービスお申し込み